ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 41 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,209,000 | -40.4% | 1,421,000 | -38.1% | 0.00% | -50.0% |
Q1 2019 | $2,027,000 | +289.1% | 2,297,000 | +264.6% | 0.00% | +300.0% |
Q4 2018 | $521,000 | -2.1% | 630,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $532,000 | -48.5% | 630,000 | -41.1% | 0.00% | -50.0% |
Q2 2018 | $1,034,000 | -60.2% | 1,070,000 | -62.5% | 0.00% | -50.0% |
Q1 2018 | $2,595,000 | -11.6% | 2,855,000 | -16.9% | 0.00% | -20.0% |
Q4 2017 | $2,937,000 | +1.7% | 3,435,000 | +7.3% | 0.01% | 0.0% |
Q3 2017 | $2,888,000 | – | 3,200,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 8,750,000 | $6,650,000 | 3.76% |
Mohican Financial Management, LLC | 3,000,000 | $2,280,000 | 2.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 11,200,000 | $8,512,000 | 1.28% |
ANGELO GORDON & CO., L.P. | 22,500,000 | $17,100,000 | 1.26% |
Context Capital Management, LLC | 1,500,000 | $1,140,000 | 1.25% |
Opera Trading Capital | 4,500,000 | $3,400,000 | 1.02% |
Jabre Capital Partners S.A. | 6,650,000 | $5,037,000 | 0.58% |
Castle Creek Arbitrage, LLC | 6,000,000 | $4,576,000 | 0.44% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 28,000,000 | $21,345,000,000 | 0.41% |
Man Investments (CH) AG | 700,000 | $536,000 | 0.31% |